VRC-HIVMAB075-00-AB (VRC07-523LS)

VRC07-523LS · NIH/NIAID Vaccine Research Center

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VRC-HIVMAB075-00-AB (VRC07-523LS), covering 2022-03-21 to 2025-05-23. Get the full timeline:

Most recent: Clinical Trial Update: Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1 [Phase 2]

See pricing